Volumetric directional optical coherence tomography.


Journal

Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630

Informations de publication

Date de publication:
01 Feb 2022
Historique:
received: 05 11 2021
revised: 14 01 2022
accepted: 14 01 2022
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 15 3 2022
Statut: epublish

Résumé

Photoreceptor loss and resultant thinning of the outer nuclear layer (ONL) is an important pathological feature of retinal degenerations and may serve as a useful imaging biomarker for age-related macular degeneration. However, the demarcation between the ONL and the adjacent Henle's fiber layer (HFL) is difficult to visualize with standard optical coherence tomography (OCT). A dedicated OCT system that can precisely control and continuously and synchronously update the imaging beam entry points during scanning has not been realized yet. In this paper, we introduce a novel imaging technology, Volumetric Directional OCT (VD-OCT), which can dynamically adjust the incident beam on the pupil without manual adjustment during a volumetric OCT scan. We also implement a customized spoke-circular scanning pattern to observe the appearance of HFL with sufficient optical contrast in continuous cross-sectional scans through the entire volume. The application of VD-OCT for retinal imaging to exploit directional reflectivity properties of tissue layers has the potential to allow for early identification of retinal diseases.

Identifiants

pubmed: 35284155
doi: 10.1364/BOE.447882
pii: 447882
pmc: PMC8884206
doi:

Types de publication

Journal Article

Langues

eng

Pagination

950-961

Subventions

Organisme : NEI NIH HHS
ID : R01 EY023285
Pays : United States

Informations de copyright

© 2022 Optica Publishing Group under the terms of the Optica Open Access Publishing Agreement.

Déclaration de conflit d'intérêts

David Huang: Optovue Inc. (F, I, P, R). Brandon J. Lujan: Direction OCT, UC Berkeley (I). Yifan Jian: Seymour Vision (O). These potential conflicts of interest have been reviewed and managed by OHSU. Other authors declare no relevant conflicts of interest related to this article.

Références

Biomed Opt Express. 2017 Nov 13;8(12):5560-5578
pubmed: 29296488
J Biomed Opt. 2014 Feb;19(2):026001
pubmed: 24503636
J Biomed Opt. 2019 Jun;24(6):1-10
pubmed: 31254332
Opt Lett. 2020 May 1;45(9):2612-2615
pubmed: 32356829
JAMA Ophthalmol. 2014 Mar;132(3):338-45
pubmed: 24626824
Exp Eye Res. 2018 Mar;168:69-76
pubmed: 29352993
Biomed Opt Express. 2021 May 20;12(6):3553-3570
pubmed: 34221678
PLoS One. 2009 Oct 19;4(10):e7507
pubmed: 19838301
Biomed Opt Express. 2015 Aug 17;6(9):3405-19
pubmed: 26417510
Ophthalmology. 1984 Jun;91(6):603-12
pubmed: 6462623
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5363-7
pubmed: 17122125
Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7640-6
pubmed: 21873669
Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec;41 Suppl:S6-S14
pubmed: 21117603
J Glaucoma. 2000 Feb;9(1):56-62
pubmed: 10708233
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):101-8
pubmed: 20720228
Ophthalmologica. 2011;226(4):182-90
pubmed: 21865677
Retina. 2011 Mar;31(3):497-501
pubmed: 21102368
Arch Ophthalmol. 2004 Apr;122(4):564-72
pubmed: 15078675
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2824-30
pubmed: 17525218
Invest Ophthalmol Vis Sci. 2011 Jun 06;52(7):3943-54
pubmed: 21421869
Retina. 2015 Aug;35(8):1511-20
pubmed: 25829348
Ophthalmology. 2014 May;121(5):1079-91
pubmed: 24433969
Nat Biomed Eng. 2021 Jul;5(7):726-736
pubmed: 34253888
Arch Ophthalmol. 2009 Sep;127(9):1168-74
pubmed: 19752426
Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3545-53
pubmed: 22570340
Opt Express. 2008 Apr 28;16(9):6486-501
pubmed: 18516251
Biomed Opt Express. 2020 Jun 24;11(7):3968-3984
pubmed: 33014579
Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1236-49
pubmed: 8641827
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1378-1386
pubmed: 28253400
Br J Ophthalmol. 1981 Jan;65(1):23-8
pubmed: 7448155
Biomed Opt Express. 2020 Jun 24;11(7):3952-3967
pubmed: 33014578
Neurobiol Aging. 2009 May;30(5):819-28
pubmed: 17920161
J Biomed Opt. 2013 Feb;18(2):26002
pubmed: 23377003
Invest Ophthalmol Vis Sci. 2011 Mar 18;52(3):1486-92
pubmed: 21071737

Auteurs

Shuibin Ni (S)

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.
Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon 97239, USA.

Shanjida Khan (S)

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.
Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon 97239, USA.

Thanh-Tin P Nguyen (TP)

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.

Ringo Ng (R)

School of Engineering Science, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.

Brandon J Lujan (BJ)

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.

Ou Tan (O)

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.

David Huang (D)

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.
Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon 97239, USA.

Yifan Jian (Y)

Casey Eye Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.
Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon 97239, USA.

Classifications MeSH